receiving speaking fees from AstraZeneca, Bayer, Boehringer Ingelheim, Impulse Dynamics, Merck, and Vifor Pharma
Some common side effects of GLP-1 medications include: Nausea and vomiting Diarrhea Constipation Abdominal pain Loss of appetite Headaches Infection Irritation at the injection site Patients on GLP-1 therapies can also experience muscle loss or bone density loss with prolonged use, which can compound some of the natural physical changes that accompany menopause
Moreover, improvements in drug formulations (such as those which do not require reconstitution or dose titration) and injection devices with hidden and pre-attached needles, which together serve to reduce treatment complexity, may lead to a more positive injection experience for patients (Table 3) [68]
However, it remains under investigation whether these benefits are directly due to the GLP-1 agonists or a result of the weight loss they facilitate